Chat with us

Nullam dignissim, ante scelerisque the is euismod fermentum odio sem semper the is erat, a feugiat leo urna eget eros. Duis Aenean a imperdiet risus.

Contact Info

Get A Ticket
Registration

International Conference on HIV, AIDS & Infectious Diseases 2027
Advancing HIV Science, Prevention, Treatment & Global Infectious Disease Research

00

Days

00

HRS

00

Mins

00

Secs

May 18–19, 2027

Orlando, USA

Join The Event

Why You Should Join Our Event

Connect with global professionals, share knowledge, discover innovation, and create meaningful opportunities through international conferences designed for researchers, academics, healthcare professionals, industry leaders, technology experts, entrepreneurs, and innovators.

img

Hear From Experts

Gain insights from leading researchers, professionals, academics, and industry experts sharing knowledge, experience, and emerging developments.

img

Build Global Connections

Meet researchers, professionals, decision-makers, entrepreneurs, and industry leaders from around the world.

img

Engage & Exchange Ideas

Participate in presentations, panel discussions, Q&A sessions, workshops, and interactive knowledge-sharing activities.

img

Create New Opportunities

Explore research collaborations, professional partnerships, business connections, and opportunities for international growth.

HIVID2027

About the Conference

The International Conference on HIV, AIDS & Infectious Diseases 2027 will bring together researchers, clinicians, healthcare professionals, scientists, public health experts, policymakers, industry representatives, and emerging researchers from around the world to explore the latest developments in HIV science, AIDS research, prevention, treatment, and the wider field of infectious diseases.



Taking place on May 18–19, 2027, in Orlando, USA, the conference will provide an international platform for scientific exchange, multidisciplinary collaboration, and discussion of research and innovations that are shaping the future of infectious disease prevention, diagnosis, treatment, and global health.



The conference will explore the evolving landscape of HIV research, including advances in prevention technologies, antiretroviral therapies, long-acting treatment approaches, vaccine development, immunology, viral reservoirs, cure research, coinfections, comorbidities, and strategies to improve access to prevention and care.

In addition to its strong focus on HIV and AIDS, the conference will address important developments across infectious disease research, including emerging and re-emerging infections, viral diseases, antimicrobial resistance, diagnostics, vaccines, epidemiology, public health preparedness, and global health security.


Under the theme:

“Advancing HIV Science, Prevention, Treatment & Global Infectious Disease Research”


the conference aims to encourage meaningful dialogue between laboratory science, clinical practice, public health, technology, and policy.


The International Conference on HIV, AIDS & Infectious Diseases 2027 will provide opportunities to present research, share clinical experiences, explore emerging technologies, establish collaborations, and connect with experts working to address some of the world's most significant infectious disease challenges.

  • img
    Expert Keynote Sessions

    Learn from leading experts and thought leaders sharing knowledge, research, innovations, and industry insights.

  • img
    Global Networking Opportunities

    Meet professionals from around the world, exchange ideas, build connections, and discover opportunities for collaboration.

img
img
Topics

Scientific Sessions

Explore our scientific sessions featuring experts, researchers, and professionals sharing the latest developments, discoveries, and innovations.

  • HIV Virology, Pathogenesis & Basic Science
    • HIV biology and replication
    • Viral structure and evolution
    • HIV transmission mechanisms
    • Virus-host interactions
    • HIV pathogenesis
    • Viral persistence
    • HIV reservoirs
    • Cellular and molecular mechanisms
    • HIV genetics and genomics
    • Viral diversity and drug resistance
    • Host factors influencing HIV infection
    • Emerging laboratory models
  • HIV Prevention & Public Health Strategies
    • HIV prevention strategies
    • Pre-exposure prophylaxis
    • Post-exposure prophylaxis
    • HIV testing and screening
    • Early diagnosis
    • Combination prevention
    • Treatment as prevention
    • Behavioral interventions
    • Community-based prevention
    • Prevention service delivery
    • Prevention among priority populations
    • Digital and technology-enabled prevention
    Prevention, including vaccines, PrEP, testing, and other biomedical and public health approaches, remains a central research priority.
  • HIV Treatment & Antiretroviral Therapy
    • Antiretroviral therapy
    • Long-acting HIV treatment
    • Novel antiretroviral agents
    • Treatment optimization
    • Drug resistance
    • Treatment adherence
    • Retention in care
    • Personalized HIV treatment
    • Treatment safety and tolerability
    • Drug interactions
    • Aging with HIV
    • Long-term clinical outcomes
  • HIV Cure, Viral Remission & Reservoir Research
    • HIV cure research
    • Functional cure
    • ART-free viral remission
    • Viral eradication
    • HIV latency
    • HIV reservoirs
    • Reservoir measurement
    • Immune-based therapies
    • Therapeutic vaccines
    • Gene and cell-based approaches
    • Latency reversal and silencing strategies
    • Cure trial design and ethics
    Research toward sustained viral remission and, ultimately, viral eradication remains a major scientific priority, with persistent viral reservoirs representing a central challenge.
  • HIV Vaccines, Immunology & Immune-Based Therapies
    • HIV vaccine research
    • Preventive vaccines
    • Therapeutic vaccines
    • Broadly neutralizing antibodies
    • Monoclonal antibodies
    • T-cell immunity
    • B-cell responses
    • Immune modulation
    • Mucosal immunity
    • Immunogen design
    • Correlates of protection
    • Next-generation vaccine platforms
  • HIV Coinfections, Comorbidities & Clinical Complications
    • HIV and tuberculosis
    • HIV and viral hepatitis
    • Sexually transmitted infections
    • Opportunistic infections
    • Cardiovascular complications
    • Cancer and malignancies
    • Neurological complications
    • Metabolic disorders
    • Kidney and liver disease
    • Mental health
    • Substance use
    • Chronic inflammation
    • Multimorbidity and aging
  • HIV Across the Lifespan & Special Populations
    • Pediatric HIV
    • Adolescent HIV
    • Women's health and HIV
    • Pregnancy and maternal health
    • Prevention of vertical transmission
    • HIV in older adults
    • Aging and long-term care
    • HIV in underserved populations
    • Health disparities
    • Social determinants of health
    • Population-specific prevention and care
  • Epidemiology, Surveillance & Implementation Science
    • HIV epidemiology
    • Disease surveillance
    • Molecular epidemiology
    • Transmission dynamics
    • Outbreak detection
    • Implementation science
    • Prevention program evaluation
    • Healthcare delivery models
    • Linkage to care
    • Retention in care
    • Health systems research
    • Dissemination of evidence-based interventions
    Implementation research is increasingly important for improving uptake, delivery, adoption, and long-term integration of effective prevention and treatment strategies.
  • Infectious Disease Research & Emerging Pathogens
    • Emerging infectious diseases
    • Re-emerging infectious diseases
    • Viral infections
    • Bacterial infections
    • Parasitic diseases
    • Zoonotic infections
    • Emerging pathogens
    • Pandemic preparedness
    • Outbreak response
    • Global infectious disease surveillance
    • One Health approaches
    • Climate and infectious diseases
  • Vaccines, Immunization & Infectious Disease Prevention
    • Vaccine research and development
    • Novel vaccine platforms
    • Immunization strategies
    • Vaccine effectiveness
    • Vaccine safety
    • Vaccine hesitancy
    • Adult immunization
    • Global vaccination programs
    • Immunology and protective immunity
    • Vaccines for emerging pathogens
    • Equity and access to vaccination
  • Antimicrobial Resistance & Infectious Disease Therapeutics
    • Antimicrobial resistance
    • Antimicrobial stewardship
    • Drug-resistant infections
    • Novel antibiotics
    • Antiviral therapies
    • Antifungal therapies
    • Drug discovery
    • Alternative antimicrobial strategies
    • Bacteriophages
    • Host-directed therapies
    • Therapeutic innovation
    • Global AMR surveillance
  • Diagnostics, Microbiology & Precision Infectious Disease Medicine
    • Rapid diagnostics
    • Point-of-care testing
    • Molecular diagnostics
    • Genomic sequencing
    • Biomarkers
    • AI in infectious disease diagnostics
    • Digital health technologies
    • Laboratory innovation
    • Diagnostic access
    • Precision medicine
    • Biosensors
    • Next-generation testing platforms
  • Global Health, Health Equity & Infectious Disease Policy
    • Global health strategies
    • Health equity
    • Access to treatment
    • Access to prevention
    • Health disparities
    • Healthcare systems
    • Global infectious disease policy
    • Community engagement
    • International health programs
    • Capacity building
    • Research infrastructure
    • Sustainable healthcare solutions
  • Digital Health, Artificial Intelligence & Future Technologies
    • Artificial intelligence in infectious disease research
    • Machine learning and disease prediction
    • Digital epidemiology
    • AI-assisted diagnostics
    • Digital health platforms
    • Telemedicine
    • Big data and public health
    • Predictive analytics
    • Wearable technologies
    • Remote patient monitoring
    • Digital interventions for prevention and adherence

Join with us

Registration Early Bird Pricing

SPEAKER

In-Person

$649

Register now

WHAT’S INCLUDED

  • Breakfast, Lunch, Free Parking
  • Standard Networking Opportunities
  • Recording of All Talks
  • Premium Conference Materials

LISTENER

In-Person

$749

Register now

WHAT’S INCLUDED

  • Breakfast, Lunch, Free Parking
  • Standard Networking Opportunities
  • Recording of All Talks
  • Premium Conference Materials

VIRTUAL

Online Presentation

$499

Register now

WHAT’S INCLUDED

  • Recording of All Talks
  • Standard Networking Opportunities
  • Webinar Link
  • Premium Conference Materials
Frequently question

Have Any Question? Find
Answer Below

  • When should I arrive at the event?
    We encourage all our speakers to attend from beginning of the conference. Many of our delegates might have seen your name in our Scientific program and wants to meet you. If this is not possible, we recommend you to arrive at least an hour before the commencement of your speech and preferably during a break in the program. This will allow you to go through your slides with our AV technician.
  • How is the program structured?
    Our program is structured to encourage the interaction between speakers and the audience. If you are presenting a single Track, we request you to keep your slides short, colorful and informative. Allow enough time for questions at the end of your presentation and try to keep it interesting.
  • How will the conference room be like?
    You will be asked to speak from a lectern on the stage in the conference hall. If you are Track chair, you will be seated in front of the stage throughout your session. Audience Q&A will be held at the end of each session, except during panels when moderators tend to keep things more interactive.
  • What if there are changes to the program schedule?
    The organizing committee tries to minimize disruption to conference program as much as possible, but sometimes it is unavoidable. If there is a change in the program with regards to your talk time, the conference organizer will contact you as soon as possible. We will inform the delegates on the day and reproduce new copies of the program agenda in the conference workbooks. Last minute changes will be communicated as soon as they are known and you will be informed immediately about the changes that affect your talk time.
View More
img
img

24/7

Support Center

Location

Conference Venue

Orlando, Florida, USA

The International Conference on HIV, AIDS & Infectious Diseases 2027 will take place in Orlando, Florida, USA, a globally recognized destination for conferences, healthcare meetings, scientific events, and international gatherings.

Orlando offers a professional and accessible environment for bringing together researchers, clinicians, healthcare professionals, public health experts, scientists, industry representatives, policymakers, and emerging researchers from around the world.

The conference venue will provide a professional setting for keynote presentations, scientific sessions, oral presentations, poster presentations, panel discussions, networking activities, and industry engagement.


A Convenient Setting for Global Collaboration

Orlando's established conference infrastructure makes it well suited for an international scientific meeting. The city hosts major healthcare, scientific, academic, and professional conferences throughout the year, with a wide range of conference hotels and dedicated meeting facilities.

The wider International Drive area is particularly well known for large-scale conference facilities and hotels, including venues located around the Orange County Convention Center.


Conference Experience

Delegates attending the conference can expect an environment designed to encourage:

  • Scientific exchange and knowledge sharing
  • Research presentations and expert discussions
  • Multidisciplinary collaboration
  • Professional networking
  • Academic and industry engagement
  • Research partnerships and future collaborations
  • Interaction between healthcare, science, technology, and public health communities


Accommodation & Travel

Orlando offers a broad selection of hotels and accommodation options suitable for international delegates, ranging from conference hotels to full-service resorts and other nearby properties.

Official accommodation information, including the conference hotel, venue address, room rates, booking information, and any special conference accommodation arrangements, will be announced by the organizing team once finalized.


Join Us in Orlando

International Conference on HIV, AIDS & Infectious Diseases 2027
May 18–19, 2027
Orlando, Florida, USA

Join researchers, clinicians, scientists, healthcare professionals, public health experts, industry leaders, and policymakers for two days of scientific discussion, collaboration, and knowledge exchange focused on the future of HIV, AIDS, and infectious disease research.

Venue details will be announced soon.

  • imgMay 18–19, 2027

  • img10:00 AM – 6:00 PM

img Orlando, USA

Get Directions
img
img
img
img
img
img
img
img

Subscribe to our newsletter
for daily updates